Flowers Foods, Inc. (NYSE: FLO) has reported adjusted earnings per share (EPS) of $0.38 for the first quarter of fiscal 2023, meeting the consensus estimate. However, due to a slow start to the year and lower-than-expected branded retail sales resulting from softer category demand, the company is adjusting its outlook for fiscal 2023. 

Flowers Foods is revising its adjusted EPS outlook to a range of approximately $1.15 to $1.25, down from the previously expected range of approximately $1.20 to $1.30. As a result, $FLO is trading at $27.42 in after-hours, reflecting a decrease of $1.42 (-4.92%).

Cavco Industries, Inc. (Nasdaq: CVCO) has released its fourth-quarter fiscal 2023 earnings, reporting an EPS of $5.39, surpassing the consensus estimate of $5.10. However, in after-hours trading, $CVCO is experiencing a decline, currently trading at $288.00, reflecting a decrease of $5.39 (-1.84%).

OncoSec Medical Incorporated (Nasdaq: ONCS) has announced the closing of a registered direct offering of 1,408,384 shares of its common stock priced at-the-market under Nasdaq rules, raising $1.33 million. The company intends to utilize the net proceeds from this offering as working capital for general corporate purposes. 

Following the announcement, $ONCS is trading at $0.56 in after-hours, showing an increase of $0.04 (+7.22%).

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)